Synonym
SAJ-310; SAJ310; SAJ 310;
IUPAC/Chemical Name
5-methoxy-2-(pyridin-2-ylmethoxy)benzaldehyde
InChi Key
PZJIEYBOHZIPIN-UHFFFAOYSA-N
InChi Code
InChI=1S/C14H13NO3/c1-17-13-5-6-14(11(8-13)9-16)18-10-12-4-2-3-7-15-12/h2-9H,10H2,1H3
SMILES Code
COC1=CC(C=O)=C(OCC2=NC=CC=C2)C=C1
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
243.26
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Richter-Addo GB. A structure-guided approach to ameliorate sickle cell disease. Acta Crystallogr D Struct Biol. 2018 Nov 1;74(Pt 11):1039-1040. doi: 10.1107/S2059798318014997. Epub 2018 Oct 30. PMID: 30387762.
2: Deshpande TM, Pagare PP, Ghatge MS, Chen Q, Musayev FN, Venitz J, Zhang Y, Abdulmalik O, Safo MK. Rational modification of vanillin derivatives to stereospecifically destabilize sickle hemoglobin polymer formation. Acta Crystallogr D Struct Biol. 2018 Oct 1;74(Pt 10):956-964. doi: 10.1107/S2059798318009919. Epub 2018 Oct 2. PMID: 30289405; PMCID: PMC6173052.
3: Pagare PP, Ghatge MS, Musayev FN, Deshpande TM, Chen Q, Braxton C, Kim S, Venitz J, Zhang Y, Abdulmalik O, Safo MK. Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease. Bioorg Med Chem. 2018 May 15;26(9):2530-2538. doi: 10.1016/j.bmc.2018.04.015. Epub 2018 Apr 6. PMID: 29655608; PMCID: PMC5935541.